{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T11:30:37Z","timestamp":1781955037574,"version":"3.54.5"},"reference-count":26,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,9]],"date-time":"2022-11-09T00:00:00Z","timestamp":1667952000000},"content-version":"vor","delay-in-days":2413,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1111\/jth.13272","type":"journal-article","created":{"date-parts":[[2016,1,25]],"date-time":"2016-01-25T06:20:59Z","timestamp":1453702859000},"page":"695-703","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Impact of point\u2010of\u2010care international normalized ratio monitoring on quality of treatment with vitamin K antagonists in non\u2010self\u2010monitoring patients: a cohort study"],"prefix":"10.1016","volume":"14","author":[{"given":"J.S.","family":"Biedermann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"van Rein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.M.H.P.","family":"van den Besselaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.N.","family":"Buhre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.P.M.","family":"de Maat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.J.M.","family":"van der Meer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.W.G.","family":"Leebeek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.J.H.A.","family":"Kruip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/jth.13272_bb0010","doi-asserted-by":"crossref","first-page":"e152S","DOI":"10.1378\/chest.11-2295","article-title":"Evidence\u2010based management of anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence\u2010Based Clinical Practice Guidelines","volume":"141","author":"Holbrook","year":"2012","journal-title":"Chest"},{"key":"10.1111\/jth.13272_bb0015","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1001\/archinte.167.3.239","article-title":"Comparison of outcomes among patients randomized to warfarin therapy according to anticoagulant control: results from SPORTIF III and V","volume":"167","author":"White","year":"2007","journal-title":"Arch Intern Med"},{"key":"10.1111\/jth.13272_bb0020","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1161\/CIRCOUTCOMES.108.796185","article-title":"Anticoagulation control and prediction of adverse events in patients with atrial fibrillation: a systematic review","volume":"1","author":"Wan","year":"2008","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1111\/jth.13272_bb0025","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1160\/TH11-05-0353","article-title":"Risks of stroke and mortality associated with suboptimal anticoagulation in atrial fibrillation patients","volume":"106","author":"Gallagher","year":"2011","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.13272_bb0030","unstructured":"Federation of Dutch Thrombosis Services. Summary annual medical reports 2013. http:\/\/www.fnt.nl\/. Accessed 18 February 2014."},{"key":"10.1111\/jth.13272_bb0035","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/BF00133081","article-title":"Advances in the monitoring of oral anticoagulation: point\u2010of\u2010care testing, patient self\u2010monitoring, and patient self\u2010management","volume":"3","author":"Leaning","year":"1996","journal-title":"J Thromb Thrombolysis"},{"key":"10.1111\/jth.13272_bb0040","first-page":"1","article-title":"Point\u2010of\u2010care international normalized ratio (INR) monitoring devices for patients on long\u2010term oral anticoagulation therapy: an evidence\u2010based analysis","volume":"9","year":"2009","journal-title":"Ont Health Technol Assess Ser"},{"key":"10.1111\/jth.13272_bb0045","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1046\/j.1365-2141.2002.03888.x","article-title":"Reliability of point\u2010of\u2010care prothrombin time testing in a community clinic: a randomized crossover comparison with hospital laboratory testing","volume":"119","author":"Shiach","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1111\/jth.13272_bb0050","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s11239-006-5584-7","article-title":"Oral anticoagulation control: the European perspective","volume":"21","author":"Fitzmaurice","year":"2006","journal-title":"J Thromb Thrombolysis"},{"key":"10.1111\/jth.13272_bb0055","unstructured":"Federation of Dutch Thrombosis Services. De kunst van het doseren [in Dutch], 3rd edn, 2014. http:\/\/www.fnt.nl. Accessed 18 February 2014."},{"key":"10.1111\/jth.13272_bb0060","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1055\/s-0038-1651587","article-title":"A method to determine the optimal intensity of oral anticoagulant therapy","volume":"69","author":"Rosendaal","year":"1993","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.13272_bb0065","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/0735-1097(96)00020-4","article-title":"Optimal intensity of oral anticoagulant therapy after myocardial infarction","volume":"27","author":"Azar","year":"1996","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/jth.13272_bb0070","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1111\/j.1538-7836.2010.03996.x","article-title":"Patient characteristics associated with oral anticoagulation control: results of the Veterans AffaiRs Study to Improve Anticoagulation (VARIA)","volume":"8","author":"Rose","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.13272_bb0075","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1538-7836.2011.04568.x","article-title":"Precision and accuracy of point\u2010of\u2010care testing coagulometers used for self\u2010testing and self\u2010management of oral anticoagulation therapy","volume":"10","author":"Christensen","year":"2012","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.13272_bb0080","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.thromres.2015.06.037","article-title":"Agreement between Coaguchek XS and STA\u2010R Evolution (Hepato Quick) INR results depends on the level of INR","volume":"136","author":"Biedermann","year":"2015","journal-title":"Thromb Res"},{"key":"10.1111\/jth.13272_bb0085","doi-asserted-by":"crossref","first-page":"470","DOI":"10.3109\/00365513.2014.902098","article-title":"The influence of coagulation factors on the in\u2010treatment biological variation of international normalized ratio for patients on warfarin","volume":"74","author":"Solvik","year":"2014","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1111\/jth.13272_bb0090","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/s003920170019","article-title":"[INR Self\u2010management after mechanical heart valve replacement: ESCAT (Early Self\u2010Controlled Anticoagulation Trial)] INR\u2010Selbstmanagement nach mechanischem Herzklappenersatz: ESCAT (Early Self\u2010Controlled Anticoagulation Trial)","volume":"90","author":"Kortke","year":"2001","journal-title":"Z Kardiol"},{"key":"10.1111\/jth.13272_bb0095","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1136\/bmj.38618.580903.AE","article-title":"Self management of oral anticoagulation: randomised trial","volume":"331","author":"Fitzmaurice","year":"2005","journal-title":"BMJ"},{"key":"10.1111\/jth.13272_bb0100","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.ejim.2005.11.021","article-title":"Self\u2010management versus conventional management of oral anticoagulant therapy: a randomized, controlled trial","volume":"17","author":"Christensen","year":"2006","journal-title":"Eur J Intern Med"},{"key":"10.1111\/jth.13272_bb0105","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1056\/NEJMoa1002617","article-title":"Effect of home testing of international normalized ratio on clinical events","volume":"363","author":"Matchar","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1111\/jth.13272_bb0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-142-1-200501040-00006","article-title":"Comparing self\u2010management of oral anticoagulant therapy with clinic management: a randomized trial","volume":"142","author":"Menendez\u2010Jandula","year":"2005","journal-title":"Ann Intern Med"},{"key":"10.1111\/jth.13272_bb0115","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1160\/TH08-06-0361","article-title":"Self\u2010management of oral anticoagulation reduces major outcomes in the elderly. A randomized controlled trial","volume":"100","author":"Siebenhofer","year":"2008","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.13272_bb0120","first-page":"111","article-title":"Anticoagulation therapy home and office monitoring evaluation study","volume":"12","author":"Kaatz","year":"2001","journal-title":"J Thromb Thrombolysis"},{"key":"10.1111\/jth.13272_bb0125","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/S0140-6736(11)61294-4","article-title":"Self\u2010monitoring of oral anticoagulation: systematic review and meta\u2010analysis of individual patient data","volume":"379","author":"Heneghan","year":"2012","journal-title":"Lancet"},{"key":"10.1111\/jth.13272_bb0130","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1111\/j.1538-7836.2004.00659.x","article-title":"Patient self\u2010management of oral anticoagulant care vs. management by specialized anticoagulation clinics: positive effects on quality of life","volume":"2","author":"Gadisseur","year":"2004","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.13272_bb0135","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1160\/TH08-04-0116","article-title":"Pharmacogenetic differences between warfarin, acenocoumarol and phenprocoumon","volume":"100","author":"Beinema","year":"2008","journal-title":"Thromb Haemost"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjth.13272","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjth.13272","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622046475?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622046475?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/jth.13272\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T03:15:53Z","timestamp":1761534953000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622046475"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["S1538783622046475"],"URL":"https:\/\/doi.org\/10.1111\/jth.13272","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of point\u2010of\u2010care international normalized ratio monitoring on quality of treatment with vitamin K antagonists in non\u2010self\u2010monitoring patients: a cohort study","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/jth.13272","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}